University of Wisconsin–Madison

New Drug Therapies

2017 Fall Distance Learning Experience

Each year the FDA approves many new drugs for a wide variety of diseases.  This year’s Fall Distance Learning Experience will explore the latest therapies for diabetes, oncology, MS, biosimilars, pediatrics, HIV, infectious disease and organ transplants.

Jointly provided by

  • University of Wisconsin-Madison School of Pharmacy, Division of Pharmacy Professional Development
  • University of Wisconsin-Madison School of Nursing, Continuing Education in Nursing

 

New Drug Therapies

Registration Information

Register

Refund Policy

Course date:Sep 12, 2017 - Sep 12, 2020
Location:
Course fee:

$150

Supplemental:
$52.75 (includes tax): Workbook (printed slides) or Thumbdrive (must be ordered by August 22, 2017).

UW Clinical Instructors & Retired Pharmacists:

Clinical instructors for selected UW School of Pharmacy experiential programs (e.g., 740, 741 & 760), who provide at least six lecture/discussion hours for SOP courses and retired pharmacists qualify for the reduced course fee.

Course Objectives

Each year the FDA approves many new drugs for a wide variety of diseases.  This year’s Fall Distance Learning Experience will explore the latest therapies for diabetes, oncology, MS, biosimilars, pediatrics, nephrology, HIV, infectious disease and organ transplants.

Learning Objectives (each lecture will have its own set of learning objectives)

At the end of this course, students will be able to:

  • Categorize the presented new agents for diabetes mellitus and explain the pharmacokinetics of each new agent;
  • List advantages of new therapies for MS;
  • Identify toxicities associated with new anti-PD-1 monoclonal antibodies used to treat cancer;
  • State indications for newly approved pediatric medications;
  • Discuss the concepts of interchangeability and substitutability between a reference biologic and a biosimilar and describe the role of the pharmacist in managing an interchangeable or substitutable biosimilar;
  • Explain the advantages and place in therapy for the most recently approved antiretroviral medications for the treatment of HIV-1;
  • Describe how healthcare professionals within their roles and as part of a team can educate patients about new drugs;
  • Identify procurement challenges with newly approved chemotherapy agents and
  • Describe the need for new immunosuppressive agents in transplantation and explain the role and benefit of the novel immunosuppressive agents.

Course Outline

 

Lecture 1

New Pharmacotherapeutic Agents for Diabetes
Denise Walbrandt-Pigarelli, PharmD, CDE

Lecture 2

New Disease Modifying Therapies in the treatment of MS
Jacci Bainbridge, PharmD, FCCP

Lecture 3

New Oncology Therapies
Mary S. Mably, RPh, BCOP

Lecture 4

New Pediatric Drug Therapies
Jessica Poehls, PharmD, BCPPS

Lecture 5

Biosimilars
Sara S. Shull, PharmD, MBA, BCPS

Lecture 6

New Therapies for HIV and Infectious Disease
Marie H. Pietruszka PharmD BCPS AAHIVP CNSC

Lecture 7

The Supply Chain, Cost and Value of Cancer Care
Heather Jones, PharmD, MS

Lecture 8

Immunosuppression Update
Daniel C Felix, PharmD, BCPS

Instructors

Jacci Bainbridge, PharmD, FCCP
Professor, Department of Clinical Pharmacy
University of Colorado
Aurora, CO

Daniel C Felix, PharmD, BCPS
Clinical Pharmacist – Abdominal Transplant
Clinical Instructor UWHealth
University of Wisconsin Hospital and Clinics
Pharmacy Services
Madison, WI

Heather Jones, PharmD, MS
Manager of Oncology Pharmacy Services
UW Health
Madison, WI

Mary S. Mably, RPh, BCOP
Supervisor, Oncology Pharmacy Programs
PGY2 Oncology Pharmacy Residency Program Director
UW Health
Madison, WI

Marie H. Pietruszka PharmD BCPS AAHIVP CNSC
Clinical Pharmacist
University of Wisconsin Hospital and Clinics
Madison WI

Jessica Poehls, PharmD, BCPPS
Pediatric Clinical Pharmacist
American Family Children's Hospital
Madison, WI

Sara S. Shull, PharmD, MBA, BCPS
Drug Policy Program Analyst
Department of Pharmacy
UW Health

Denise Walbrandt-Pigarelli, PharmD, CDE
Associate Professor (CHS)
University of Wisconsin School of Pharmacy
Madison, WI

CE Credit

Interprofessional Continuing EducationIn support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin-Madison ICEP designates this live or enduring knowledge-based activity for 12 hours (1.2 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. There will be no partial credit awarded for partial attendance.

Enduring (home study): JA0000358-0000-18-030-H01-P

Release Date: 09/12/2017 Expiration Date: 9/12/2020

American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing

The University of Wisconsin-Madison ICEP designates this enduring study activity for a maximum of 8.5 ANCC and Iowa contact hours. (8.25 ANCC pharmacotherapeutic contact hours)

The University of Wisconsin-Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Suite B, Des Moines, IA 50309.

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin School of Pharmacy and School of Nursing that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259
eric.buxton@wisc.edu